Aardvark Therapeutics, Inc.
AARD
$8.49
-$0.50-5.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -54.32% | -6.05% | -109.92% | 23.25% | -150.18% |
| Total Depreciation and Amortization | 120.00% | 104.13% | -239.08% | 4,450.00% | -200.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -53.65% | -23.46% | 51.69% | 274.60% | -79.34% |
| Change in Net Operating Assets | 286.04% | -389.20% | 948.96% | -108.18% | 467.71% |
| Cash from Operations | 13.56% | -47.38% | -95.37% | 6.17% | -92.47% |
| Capital Expenditure | -- | -- | -20.00% | 94.62% | -1,760.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 108.44% | -847.30% | -- | -- | -- |
| Cash from Investing | 108.35% | -846.82% | -237,800.00% | 94.62% | -1,760.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.99% | 55,841.72% | -3.55% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 96.67% | -96.26% | -1,020.95% | 94.90% | -- |
| Cash from Financing | -100.08% | 8,864.79% | -1,684.38% | -99.92% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.56% | -70.27% | -429.67% | -104.95% | 3,682.37% |